Obstructive Lung Diseases Recruiting Phase 4 Trials for Azithromycin (DB00207)

Also known as: Obstructive Lung Disease / Lung Disease,Obstructive / Lung Disease, Obstructive / Lung Diseases, Obstructive

IndicationStatusPhase
DBCOND0068721 (Obstructive Lung Diseases)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04319705Anti-viral Effects of Azithromycin in Patients With Asthma and COPDTreatment